Market Closed -
Other stock markets
|
After market 20:59:59 | |||
26.67 EUR | +0.83% |
|
26.24 | -1.59% |
07-09 | Valmet Books Order for Tissue Production Line from Velvet Care | MT |
07-09 | Valmet to Supply the Third Advantage DCT 200 Tissue Production Line to Velvet Care Paper Mill in Poland | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Industrial Machinery & Equipment
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.14% | 5.37B | - | ||
-7.88% | 13.94B | B | ||
+119.49% | 5.61B | A- | ||
+12.06% | 4.45B | B | ||
-14.09% | 4.38B | C | ||
+12.52% | 4.37B | B- | ||
+21.10% | 4.01B | B- | ||
+16.32% | 3.88B | B- | ||
+6.71% | 3.56B | B+ | ||
-35.31% | 3.53B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VALMT Stock
- 2VO Stock
- Ratings Valmet Oyj